المؤلفون: Wang, Sijiao, Oliveira-Silveira, Juliano, Fang, Gang, Kang, Jungseog

المصدر: BMC Cancer; 3/12/2024, Vol. 24 Issue 1, p1-16, 16p

مصطلحات موضوعية: NON-small-cell lung carcinoma, HISTONE deacetylase inhibitors, DRUG interactions, MTOR inhibitors, CANCER cells, RECESSIVE genes

المؤلفون: Glaviano, Antonino, Foo, Aaron S. C., Lam, Hiu Y., Yap, Kenneth C. H., Jacot, William, Jones, Robert H., Eng, Huiyan, Nair, Madhumathy G., Makvandi, Pooyan, Geoerger, Birgit, Kulke, Matthew H., Baird, Richard D., Prabhu, Jyothi S., Carbone, Daniela, Pecoraro, Camilla, Teh, Daniel B. L., Sethi, Gautam, Cavalieri, Vincenzo, Lin, Kevin H., Javidi-Sharifi, Nathalie R.

المصدر: Molecular Cancer; 11/23/2023, Vol. 22 Issue 1, p1-37, 37p

مصطلحات موضوعية: CELLULAR signal transduction, CANCER treatment, MTOR inhibitors, CELL cycle, TRANSCRIPTION factors

المؤلفون: Ali, Eunus S.^1,2,3 (AUTHOR), Mitra, Kangkana⁴ (AUTHOR), Akter, Shamima⁵ (AUTHOR), Ramproshad, Sarker⁶ (AUTHOR), Mondal, Banani⁶ (AUTHOR), Khan, Ishaq N.⁷ (AUTHOR), Islam, Muhammad Torequl⁸ (AUTHOR), Sharifi-Rad, Javad⁹ (AUTHOR) javad.sharifirad@gmail.com, Calina, Daniela¹⁰ (AUTHOR) calinadaniela@gmail.com, Cho, William C.¹¹ (AUTHOR) chocs@ha.org.hk

المصدر: Cancer Cell International. 9/15/2022, Vol. 22 Issue 1, p1-16. 16p.

مصطلحات موضوعية: *RAPAMYCIN, *MTOR inhibitors, *IMMUNOSUPPRESSIVE agents, *CELL transformation, *CANCER treatment, *CELL proliferation

المؤلفون: Zou, Zhilin^1,2,3 (AUTHOR), Tao, Tao⁴ (AUTHOR), Li, Hongmei³ (AUTHOR) lihongmei@gdmu.edu.cn, Zhu, Xiao^1,2 (AUTHOR) xzhu@gdmu.edu.cn

المصدر: Cell & Bioscience. 3/10/2020, Vol. 10 Issue 1, p1-11. 11p.

مصطلحات موضوعية: *MTOR inhibitors, *AUTOPHAGY, *PROTEIN synthesis, *CELL metabolism, *CELL differentiation, *CANCER

المؤلفون: Bernard, Sarah, Poon, Andrew C., Tam, Peyton M., Mutsaers, Anthony J.

المصدر: BMC Veterinary Research; 12/11/2021, Vol. 17 Issue 1, p1-16, 16p

مصطلحات موضوعية: EVEROLIMUS, CANCER cells, ANTINEOPLASTIC agents, MELANOMA, RAPAMYCIN, MTOR inhibitors, CELL death, GLYCOLYSIS

المؤلفون: Ji Nie, Xuelei Ma, Jing Yang, Xiawei Wei, Yong Peng, Yuquan Wei

المصدر: Molecular Cancer
Molecular Cancer, Vol 18, Iss 1, Pp 1-28 (2019)

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Antineoplastic Agents, Review, Biology, lcsh:RC254-282, PI3K signaling, PI3K, Target therapy, 03 medical and health sciences, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, Neoplasms, medicine, Animals, Humans, Molecular Targeted Therapy, Protein kinase B, Protein Kinase Inhibitors, PI3K/AKT/mTOR pathway, Cancer, Phosphoinositide-3 Kinase Inhibitors, Clinical Trials as Topic, TOR Serine-Threonine Kinases, Master regulator, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Discovery and development of mTOR inhibitors, Clinical trial, Gene Expression Regulation, Neoplastic, 030104 developmental biology, Oncology, Tumor progression, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cancer research, mTOR, Molecular Medicine, Proto-Oncogene Proteins c-akt, Signal Transduction

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::760fbcdfb07da0c9e7201f544add6b61Test
http://europepmc.org/articles/PMC6379961Test

المؤلفون: Hua, Hui, Kong, Qingbin, Zhang, Hongying, Wang, Jiao, Luo, Ting, Jiang, Yangfu

المصدر: Journal of Hematology & Oncology; 7/5/2019, Vol. 12 Issue 1, pN.PAG-N.PAG, 1p

مصطلحات موضوعية: RAPAMYCIN, PROTEIN kinase C, INSULIN-like growth factor receptors, CANCER treatment, RIBOSOMAL proteins, MTOR inhibitors, PROTEIN kinases